Aloe vera Extract Suppresses Proliferation of Neuroblastoma Cells In Vitro

Anticancer Res. 2015 Aug;35(8):4479-85.

Abstract

Background/aim: Neuroblastoma is a pediatric solid tumor refractory to eradication by chemotherapy. To determine whether Aloe vera (AV), a pontial anticancer reagent, could be useful in neuroblastoma therapy, we investigated the anti-proliferative effects of an AV protein extract.

Materials and methods: Human neuroblastoma cell lines (IMR-32, TGW, CHP-126 and NBL-S) were cultured with AV protein extract and proliferation status was assessed by cell counting, Ki-67 staining and gene expression.

Results: Among tested lines, the number of viable, AV-treated IMR-32 cells significantly decreased 1.98-fold by day 2 and 1.33-fold by day 5 of culture relative to untreated controls (p<0.05). Treatment also decreased the number of Ki-67(+) IMR-32 cells by 13% by day 5 (p<0.05) and, unlike untreated controls, CCND2 mRNA expression levels became undetectable by day 1.

Conclusion: AV-protein extract suppresses human IMR-32 neuroblastoma cell proliferation, possibly by suppressing CCND2 transcript levels in vitro.

Keywords: Aloe vera; Neuroblastoma; proliferation.

MeSH terms

  • Aloe / metabolism*
  • Animals
  • Antineoplastic Agents / pharmacology*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects*
  • Cyclin D2 / genetics
  • Humans
  • Mice
  • Neuroblastoma / drug therapy*
  • Plant Extracts / pharmacology*
  • RNA, Messenger / biosynthesis

Substances

  • Antineoplastic Agents
  • CCND2 protein, human
  • Cyclin D2
  • Plant Extracts
  • RNA, Messenger